Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 125.4 Billion | USD 218.8 Billion | 6.5% | 2023 |
The global over-the-counter drugs market size accrued earnings worth approximately USD 125.4 Billion in 2023 and is predicted to gain revenue of about USD 218.8 Billion by 2032, is set to record a CAGR of nearly 6.5% over the period from 2024 to 2032.
The increasing population of elderly individuals and favorable regulatory policies are key factors driving the market growth rate. Additionally, the expiration of patents for many drugs, leading to their use as OTC medications, and the affordability of these drugs are contributing to the expansion of the over-the-counter (OTC) drugs market.
The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints for the over-the-counter drugs market, along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the over-the-counter drugs market on a global as well as regional level.
In order to give the users of this report a comprehensive view on the over-the-counter drugs market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segment is benchmarked based on their market size, growth rate and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the over-the-counter drugs market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the over-the-counter drugs market on global and regional basis.
Report Attributes | Report Details |
---|---|
Report Name | Over-the-Counter Drugs Market Research Report |
Market Size in 2023 | USD 125.4 Billion |
Market Forecast in 2032 | USD 218.8 Billion |
Growth Rate | CAGR of 6.5% |
Number of Pages | 199 |
Key Companies Covered | GlaxoSmithKline (GSK), Sun Pharmaceutical Industries Ltd., Bayer HealthCare, Johnson & Johnson, Pfizer, Sanofi, Alkem Laboratories Limited, Glenmark Pharmaceuticals Ltd., Cipla, Inc., Takeda, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group Plc, Innovus Pharmaceutical Inc., Piramal, and Dr. Reddy's Laboratories among others. |
Segments Covered | By Product, By End-Users, By Distribution Channel, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The study provides a decisive view of over-the-counter drugs market by segmenting the market based on by product, by end-user, by distribution channel and by region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.
By product segment analysis includes cough & flu products, analgesics, cold, weight loss products, mineral and vitamin supplements, gastrointestinal products, ophthalmic products, skin products and others.
By end-user segment analysis includes specialty clinic, home care, hospital and others.
By distribution channel segment analysis includes hospital pharmacy, retail pharmacy, online pharmacy and others.
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The countries covered in the OTC drugs market report include the U.S., Canada, Mexico, Brazil, Argentina, Peru, the rest of South America, Germany, France, the U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, the rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, the rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, and the rest of the Middle East and Africa.
North America dominates the OTC drugs market due to the presence of major key players, high disposable income, significant healthcare expenditure, and a well-developed healthcare sector in this region.
Some of the leading players in the global market include
Global Over-the-Counter Drugs Market: By Product
By End-Users
By Distribution Channel
FrequentlyAsked Questions
The increasing population of elderly individuals and favorable regulatory policies are key factors driving the market growth rate. Additionally, the expiration of patents for many drugs, leading to their use as OTC medications, and the affordability of these drugs are contributing to the expansion of the over-the-counter (OTC) drugs market.
The Over-the-Counter Drugs Market was valued at USD 125.4 Billion in 2023.
The Over-the-Counter Drugs Market is expected to reach USD 218.8 Billion by 2032, growing at a CAGR of of 6.5% between 2024 to 2032.
The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints for the over-the-counter drugs market, along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the over-the-counter drugs market on a global as well as regional level.
Global Over-the-Counter Drugs Market players such as GlaxoSmithKline (GSK), Sun Pharmaceutical Industries Ltd., Bayer HealthCare, Johnson & Johnson, Pfizer, Sanofi, Alkem Laboratories Limited, Glenmark Pharmaceuticals Ltd., Cipla, Inc., Takeda, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group Plc, Innovus Pharmaceutical Inc., Piramal, and Dr. Reddy's Laboratories among others.
The Regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed